Menopause

McNeil, Melissa; Merriam, Sarah

doi:10.7326/aitc202107200

Cited by 35 publications

(21 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…30 Women with them are more likely to experience psychological symptoms, which increase the risk of depression, stress, anxiety, and decreased sexual function. 4 The vasomotor symptoms of perimenopausal women are most commonly hot flashes and night sweats. 31 These symptoms are caused by changes in women's hormone levels and physiological characteristics, which result in women experiencing these symptoms at this stage of perimenopause.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Utilization of complementary and alternative medicine by perimenopausal women in China: a cross-sectional study

et al. 2022

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…Vasomotor symptoms are typical in perimenopause 30 . Women with them are more likely to experience psychological symptoms, which increase the risk of depression, stress, anxiety, and decreased sexual function 4 . The vasomotor symptoms of perimenopausal women are most commonly hot flashes and night sweats 31 .…”

Section: Discussionmentioning

confidence: 99%

Utilization of complementary and alternative medicine by perimenopausal women in China: a cross-sectional study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…[2] Menopause adalah proses suatu berhentinya menstruasi secara permanen yang dapat dialami oleh semua wanita dan berakhirnya kemampuan bereproduksi yang disebabkan oleh kurangnya fungsi folikel ovarium. [3] Wanita dikatakan menopause jika mereka tidak mengalami menstruasi selama setahun. Sebelum masa menopause terjadi, umumnya seorang wanita akan melewati terlebih dahulu masa premenopause, pada tahap ini akan mengalami perubahan dari masa ovulasi mendekati tidak terjadinya pembuahan.…”

Section: Pendahuluanunclassified

Tingkat Pengetahuan Tentang Menopause Dan Kesiapan Menghadapi Masa Menopause Di Desa Bumi Pratama Mandira

Mazida

Wijaya

2022

iqra_medical

View full text Add to dashboard Cite

seorang wanita akan mempunyai harapan hidup normal 25 tahun lagi sejak awal menopause. Keterangan menurut WHO pada tahun 2013 jumlah wanita yang ada di dunia dimana yang sudah mengalami masa menopause diperkirakan mencapai 1,42 miliar jiwa. Menopause adalah proses suatu berhentinya menstruasi secara permanen yang dapat dialami oleh semua wanita dan berakhirnya kemampuan bereproduksi yang disebabkan oleh kurangnya fungsi folikel ovarium. Wanita dikatakan menopause jika mereka tidak mengalami menstruasi selama setahun. Sebelum masa menopause terjadi, umumnya seorang wanita akan melewati terlebih dahulu masa premenopause. Premenopause merupakan suatu kedaan fisiologis pada wanita yang telah mengalami masa penuaan, yang dimana ditandai dengan hormone estrogen yang menurun dari ovarium yang berperan penting dalam reproduksi dan seksualitas. Tingkat pengetahuan wanita yang lebih tentang menopause membantu wanita untuk dapat menyiapkan diri dalam menghadapi menopause. Tujuan dilakukannya penelitian ini untuk mengetahui gambaran tingkat pengetahuan wanita tentang menopause dan kesiapan menghadapi menopause. Jenis dan desain penelitian yang digunakan adalah metode deskriptif. Populasi dalam penelitian ini yaitu ibu dengan rentan usia 45-55 tahun yang ada di Desa Bumi Pratama Mandira dengan jumlah responden sebanyak 201 orang. Hasil penelitian menunjukkan bahwa karateristik responden terbanyak usia kurang dari 50 tahun (58,7%), berpendidikan SD (44,8%), berpendidikan SMP (28,4%), berpendidikan SMA (23,4%), dan berpendidikan S1 (3,5%), berpengetahuan cukup (48%), berpengetahuan baik (52%), memiliki tingkat kesiapan menghadapi menopause (56,3%) dan belum siap menghadapi menopause (43,7%).

show abstract

“…As a consequence of the reduction of estrogen levels produced by such treatment, postmenopausal women are at a high risk of developing several side effects [ 6 , 7 , 8 , 9 ]. In this sense, frailty syndrome defined as a potentially reversible health condition characterized by a decrease in physiological reserve caused by impairment of multiple physiological systems [ 10 ], and leading to increased vulnerability to adverse health effects and decreased ability to react favorably to stressful events [ 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors

et al. 2022

View full text Add to dashboard Cite

Background: The standard treatment in postmenopausal women with estrogen- and progesterone-positive localized breast cancer consists of aromatase inhibitors (AROi). The ability of AROi to promote or worsen frailty syndrome over time and the relationship with changes in gonadal hormones concentration in blood have not been investigated. Methods: A prospective study to evaluate the relationship between frailty syndrome and gonadal hormones concentrations in blood at baseline (prior to AROi treatment) and after 6 and 12 months under AROi treatment in post-menopausal women with breast cancer. Frailty syndrome was evaluated by the Fried’ criteria. We evaluated whether hormone concentration at baseline could predict frailty syndrome at follow-up. Results: Multinomial regression analysis showed that of the different hormones, those significantly (p < 0.05) associated to the worsening of frailty syndrome were high androstenedione levels and low follicle-stimulating hormone (FSH) levels in blood. Receiver operating characteristic curve analysis showed both androstenedione and FSH significantly (p < 0.05) discriminate patients who developed or presented worsening of frailty syndrome over time, with acceptable sensitivity (approximately 80% in both cases) but low specificity (40%). Conclusion: Hormonal concentrations before AROi treatment constitute possible biomarkers to predict the progression of frailty syndrome.

show abstract

Menopause

Cited by 35 publications

References 65 publications

Utilization of complementary and alternative medicine by perimenopausal women in China: a cross-sectional study

Utilization of complementary and alternative medicine by perimenopausal women in China: a cross-sectional study

Tingkat Pengetahuan Tentang Menopause Dan Kesiapan Menghadapi Masa Menopause Di Desa Bumi Pratama Mandira

Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors

Contact Info

Product

Resources

About